Literature DB >> 6896321

Dissolution fractions and half-times of single source yellowcake in simulated lung fluids.

N A Dennis, H M Blauer, J E Kent.   

Abstract

Thirty-five samples of yellowcake, the primary product of uranium milling, were obtained from industry. Samples were selected from the archives of 6 yr of yellowcake production from a single uranium milling operation. Ten representative samples were selected on the basis of color variation and chemical composition. Dissolution fractions and half-times were obtained using both simulated interstitial and simulated surfactant lung fluids maintained in vials submerged in a shaker water bath at 37 degrees C for 26 days. Samples were collected at 12 different time intervals and fresh simulant replaced. Uranium concentrations were analyzed by fluorometric methods using ASTM techniques. The fraction of the uranium undissolved, F, can be well modelled by the sum of three exponential terms: (See formula in text). Dissolution fractions and half-times in the two simulated lung fluids were found to be not significantly different. The point estimates for the six parameters (three fractions of the amount of uranium and the three associated half-times for dissolution) based on the analyses are: f1 equals 16.0% and t1/2(1) equals 3.5 hr, f2 equals 16.5% and t1/2(2) equals 4.4 days, and f3 equals 67.5% and t1/2(3) equals 224 days. The final characterization of yellowcake resulting from this investigation strongly suggests that dissolution rates of yellowcake from a single source may be individually process specific or site specific.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896321     DOI: 10.1097/00004032-198204000-00007

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  2 in total

1.  Solubility of airborne radioactive fuel particles from the Chernobyl reactor and implication to dose.

Authors:  E K Garger; A D Sazhenyuk; A A Odintzov; H G Paretzke; P Roth; J Tschiersch
Journal:  Radiat Environ Biophys       Date:  2004-02-28       Impact factor: 1.925

2.  The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.

Authors:  Young-In Kim; Rajat Pareek; Ryan Murphy; Lisa Harrison; Eric Farrell; Robert Cook; John DeVincenzo
Journal:  Influenza Other Respir Viruses       Date:  2017-10-30       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.